HPV positive participants | Multiple HPV positive participants | |||
---|---|---|---|---|
n | % (95% CI) | n | % (95% CI) | |
HPV | 121 | 28.0 (23.9-32.5) | 54 | 100 |
One HPV type | 67 | 15.5 (12.3-19.4) | - | - |
Multiple HPV types | 54 | 12.5 (9.6-16.1) | - | - |
HR-HPV | 107 | 24.8 (20.8-29.2) | 53 | 98.1 (90.1-100.0) |
LR-HPV | 32 | 7.4 (5.2-10.4 | 19 | 5.8 (3.6-9.0) |
HPV 16 | 29 | 6.7 (4.6-9.6) | 21 | 38.9 (25.9-53.1) |
HPV 51 | 22 | 5.1 (3.3-7.7) | 18 | 33.3 (21.1-47.5) |
HPV 31 | 20 | 4.6 (2.9-7.2) | 12 | 22.0 (12.0-35.6) |
HPV 52 | 18 | 4.2 (2.6-6.6) | 10 | 18.5 (9.3-31.4) |
HPV 18 | 15 | 3.5 (2.0-5.8) | 12 | 22.2 (12.0-35.6) |
HPV 53 | 11 | 2.5 (1.3-4.6) | 11 | 20.4 (10.6-36.5) |
HPV 58 | 10 | 2.3 (1.2-4.4) | 8 | 14.8 (6.6-27.1) |
HPV 39 | 9 | 2.1 (1.0-4,1) | 8 | 14.8 (6.6-27.1) |
HPV 6 | 7 | 1.6 (0.7-3.5) | 6 | 11.1 (4.2-22.6) |
HPV 45 | 6 | 1.4 (0.6-3.2) | 1 | 1.9 (0.0-9.9) |
HPV 66 | 6 | 1.4 (0.6-3.2) | 3 | 5.6 (1.2-15.4) |
HPV 73 | 6 | 1.4 (0.6-3.2) | 2 | 3.7 (0.5-12.7) |
HPV 42 | 5 | 1.2 (0.4-2.8) | 3 | 5.6 (1.2-15.4) |
HPV 54 | 5 | 1.2 (0.4-2.8) | 2 | 3.7 (0.5-12.7) |
HPV 26 | 4 | 0.9 (0.3-2.5) | 2 | 3.7 (0.5-12.7) |
HPV 33 | 4 | 0.9 (0.3-2.5) | 3 | 5.6 (1.2-15.4) |
HPV 56 | 4 | 0.9 (0.3-2.5) | 2 | 3.7 (0.5-12.7) |
HPV 68 | 4 | 0.9 (0.3-2.5) | 3 | 5.6 (1.2-15.4) |
HPV 40 | 3 | 0.7 (0.2-2.2) | 1 | 1.9 (0.0-9.9) |
HPV 84 | 3 | 0.7 (0.2-2.2) | 3 | 5.6 (1.2-15.4) |
HPV 35 | 2 | 0.5 (0.1-1.8) | 2 | 3.7 (0.5-12.7) |
HPV 70 | 2 | 0.5 (0.1-1.8) | 0 | - |
HPV 55 | 2 | 0.5 (0.1-1.8) | 1 | 1.9 (0.0-9.9) |
HPV 61 | 2 | 0.5 (0.1-1.8) | 0 | - |
HPV 62 | 2 | 0.5 (0.1-1.8) | 2 | 3.7 (0.5-12.7) |
HPV 59 | 1 | 0.2 (0.0-1.5) | 1 | 1.9 (0.0-9.9) |
HPV 82 | 1 | 0.2 (0.0-1.5) | 1 | 1.9 (0.0-9.9) |
HPV 11 | 1 | 0.2 (0.0-1.5) | 0 | - |
HPV 89 | 1 | 0.2 (0.0-1.5) | 1 | 1.9 (0.0-9.9) |
HPV 44 | 1 | 0.2 (0.0-1.5) | 0 | - |